2 completed, 1 active not recruiting, 1 unknown. 2 Phase 1, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 3 | 2 | Active not recruiting 1, Unknown 1 |
Follow BCG for Therapeutic Use: new trials by email Literature Review of BCG for Therapeutic Use trials Research Report on BCG for Therapeutic Use
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| BCG for Therapeutic Use Phase Ⅲ Clinical Trial BCG for Therapeutic Use, BCG for Therapeutic Use ( BI SAI JI ) - BCG | Phase 3 | Active not recruiting | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 439 | 2025-04-08 | 2026-04-27 |
| Clinical Trial for Evaluating the Efficacy and Safety of BCG for Therapeutic Use in the Prevention of Postoperative Recurrence of Medium/High-risk Non-muscle Invasive Bladder Cancer (NMIBC) BCG for Therapeutic Use - Non-Muscle Invasive Bladder Cancer | Phase 3 | Unknown | Chengdu CoenBiotech Co., Ltd | 412 | 2023-12-28 | 2024-02-05 |
| BCG for Therapeutic Use Phase I Clinical Trial BCG for therapeutic use - Non-muscular Invasive Bladder Cancer | Phase 1 | Completed | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 10 | 2023-11-22 | 2025-05-31 |
| Clinical Study to Investigate the Safety and Tolerance of Therapeutic BCG in Postoperative Adjuvant Therapy in Subjects With Moderate to High-risk Non-muscular Invasive Bladder Cancer (NMIBC) BCG for Therapeutic Use - Non-muscular Invasive Bladder Cancer | Phase 1 | Completed | Chengdu CoenBiotech Co., Ltd | 10 | 2022-11-11 | 2024-04-05 |
Urinary Bladder Neoplasms (3) · Non-Muscle Invasive Bladder Neoplasms (1)
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. (2) · Chengdu CoenBiotech Co., Ltd (2)
China (4)